Nanotechnology Now







Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Dr. Howard Fields to Join NanoViricides as Vice-President of Virology

Abstract:
International Hepatitis Expert from CDC to Manage R&D and Collaborations

Dr. Howard Fields to Join NanoViricides as Vice-President of Virology

WEST HAVEN, CT | Posted on March 24th, 2008

NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced today that Howard Fields, PhD, currently a member of the Scientific Advisory Board, will join the Company as Vice President of Virology.

"We're very pleased to have Dr. Fields, a scientist of great international repute, joining us. He will guide, manage, and coordinate our extensive activities in all aspects of virology. His international experience in developing novel approaches to problems in virology, and in successfully managing multi-national collaborations amongst various agencies, will be of tremendous benefit to NanoViricides," said Eugene Seymour, MD, MPH, CEO of the Company.

Dr. Fields is a distinguished international expert in several areas of immunology, biochemistry, molecular biology, virology, and general microbiology. He has applied his knowledge to the study of viral hepatitis during an illustrious 32 year career at the Centers for Disease Control and Prevention publishing 160 manuscripts in international peer-reviewed journals and editing a book entitled "Artificial DNA". Dr. Fields pioneered research in using genetic engineering technology in the rational design of artificial antigens as targets for immunoassay development. He first joined CDC as an immunovirologist in 1976. During his thirty-two year career at the CDC, he was the Team Leader of the Assay Development and Cell Culture Team within the Division of Viral Hepatitis Center where he led the research on all hepatitis viruses including Hepatitis C Virus, and Hepatitis B Virus from 2002 until retiring recently.

"NanoViricides has developed a unique platform technology that is based on sound virological and biological principles. I am very pleased with the success of the nanoviricides drug candidates against numerous important viral diseases of public health significance. The novel host-cell-mimetic technology that Dr. Diwan invented has now culminated in the development of the Company's broad-spectrum antivirals. This technology represents an innovative and novel approach in the treatment of viral infections and I'm truly excited to be part of its future," said Dr. Fields.

At the CDC, in 1983, Dr. Fields was Chief, Molecular and Immunodiagnostic Section (MIDS), Hepatitis Branch, Division of Viral and Rickettsial Diseases. From 1990 to 1994, he was given the responsibility for the conduct of the WHO Collaborating Centre for Reference and Research on Viral Hepatitis at CDC with emphasis on technology transfer issues. Dr. Fields has been a consultant to various pharmaceutical industries including Bayer, Germany, Abbott Laboratories, Serologics, Inc., American Qualex, Eugene Tech International Inc., Nuclear Medical Laboratories, Dallas, TX, as well as Biokit, Barcelona, Spain, and Span Research Center, Surat, India. He is a member of the scientific advisory board of Cambridge Biotech, Galway, Ireland, and of NanoViricides, Inc.

####

About NanoViricides, Inc.
NanoViricides, Inc. (www.nanoviricides.com) is a development stage company that is creating special purpose nanomaterials for viral therapy. The Company's novel nanoviricide™ class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. The Company is developing drugs against a number of viral diseases including H5N1 bird flu, seasonal influenza, HIV, hepatitis C, rabies, Ebola virus, and dengue fever, among others.

This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Forward-looking statements involve risks and uncertainties. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by NanoViricides, Inc. are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward looking statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance, or achievements of the company to be different from those expressed or implied including the success of the Company's research and development efforts, the availability of adequate financing, the successful and timely completion of clinical studies and the uncertainties related to the regulatory process, described in the “Management’s Discussion and Analysis” section of the Company’s Form 10-KSB and other reports and filings with the Securities and Exchange Commission.

For more information, please click here

Contacts:
NanoViricides, Inc.
Amanda Schuon
310-550-7200

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Nanotech-enabled moisturizer speeds healing of diabetic skin wounds: Spherical nucleic acids silence gene that interferes with wound healing April 24th, 2015

Fast and accurate 3-D imaging technique to track optically trapped particles April 24th, 2015

Pseudoparticles travel through photoactive material: KIT scientists measure important process in the conversion of light energy -- publication in Nature Communications April 24th, 2015

Scientists Use Nanoscale Building Blocks and DNA 'Glue' to Shape 3D Superlattices: New approach to designing ordered composite materials for possible energy applications April 23rd, 2015

Nanomedicine

Nanotech-enabled moisturizer speeds healing of diabetic skin wounds: Spherical nucleic acids silence gene that interferes with wound healing April 24th, 2015

Fast and accurate 3-D imaging technique to track optically trapped particles April 24th, 2015

A silver lining: UCSB researchers cradle silver nanoclusters inside synthetic DNA to create a programmed, tunable fluorescent array April 23rd, 2015

Scientists Use Nanoscale Building Blocks and DNA 'Glue' to Shape 3D Superlattices: New approach to designing ordered composite materials for possible energy applications April 23rd, 2015

Announcements

Nanotech-enabled moisturizer speeds healing of diabetic skin wounds: Spherical nucleic acids silence gene that interferes with wound healing April 24th, 2015

Fast and accurate 3-D imaging technique to track optically trapped particles April 24th, 2015

Pseudoparticles travel through photoactive material: KIT scientists measure important process in the conversion of light energy -- publication in Nature Communications April 24th, 2015

Surface matters: Huge reduction of heat conduction observed in flat silicon channels April 23rd, 2015

Appointments/Promotions/New hires/Resignations/Deaths

Dais Analytic Corporation Appoints Eliza Wang to Board of Directors: Company's Newest Director Brings Expertise in Commercial and Legal Matters Both in the United States and China; Joins on the Heels of Successful Business Development Trade Mission to China April 18th, 2015

Nanion Technologies Appoints James Costantin as Director of Customer Relations: Nanion is pleased to announce the appointment of Dr. James Costantin as Director of Customer Relations at Nanion Technologies Inc. March 31st, 2015

Nanofilm Appoints Senior Sales/Marketing Executives: Don Tecco, Director of Optical Sales, North America and Rex Talbott, Business Director Optical Products March 23rd, 2015

KIT Increases Commitment in Asia: DAAD Funds Two New Projects: Strategic Partnerships with Chinese Universities and Communi-cation Technologies Network February 22nd, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project